Thrombectomy Clinical Trials

Clinical trials related to Thrombectomy Procedure

Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Endovascular thrombectomy (EVT) is the standard of care for acute ischemic stroke (AIS) caused by a large vessel occlusion. Successful recanalization is one of the most important factors for a good patient outcome, especially when obtained within 30 minutes from groin puncture, and the procedural success-rate reaches above 90% at treating centers of excellence. There are however a portion of cases where recanalization is not achieved, which in some cases are attributed to difficult arterial anatomy affecting the ability to catheterize the precerebral target vessel. In the latest angiography platforms, 3D reconstructions of the aortic, cervical and intracranial arteries from the preprocedural CT angiography can be fused with periprocedural 2D digital subtraction angiography and/or fluoroscopy images, so called 2D/3D Fusion imaging. The preparation steps can be done before patient arrival to the angiography suite and the image fusion can be done in less than a minute during patient preparation. Previous observational studies have shown that the use of fusion imaging during EVT procedures may decrease failed target vessel access and increase procedural success rate and first-pass recanalization rate, without prolonging the procedure. The purpose of this study is to assess the use of fusion imaging in EVT procedures and its effect on target vessel access, recanalization success-rate and procedure times.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age ≥18 years.

• Eligible for an EVT procedure

Locations
Other Locations
Finland
Helsinki University Central Hospital
NOT_YET_RECRUITING
Helsinki
Turku University Hospital
NOT_YET_RECRUITING
Turku
Sweden
Skane University Hospital Lund
RECRUITING
Lund
Örebro University Hospital
NOT_YET_RECRUITING
Örebro
Contact Information
Primary
Johan Wasselius, MD, PhD
johan.wasselius@gmail.com
+46-46173082
Time Frame
Start Date: 2026-03-02
Estimated Completion Date: 2027-05-31
Participants
Target number of participants: 300
Treatments
Active_comparator: EVT without Fusion
Standard endovascular treatment
Experimental: EVT with Fusion
Standard endovascular thrombectomy with Fusion
Related Therapeutic Areas
Sponsors
Collaborators: University of Turku, Insel Gruppe AG, University Hospital Bern, Helsinki University Central Hospital, Lund University, Örebro Läns Landsting
Leads: Region Skane

This content was sourced from clinicaltrials.gov